763-25-1-021-0001 -Lancaster CMOP ACAMPROSATE -(VA-25-00009224)
ID: 36C77025Q0016Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/42cf0c970b40428386d5a37938888c6f/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting bids for the procurement of Acamprosate CA 333MG EC Tablets under the RFQ 36C77025Q0016, specifically targeting small businesses through a total small business set-aside. The procurement requires compliance with various federal regulations, including pharmaceutical labeling, delivery conditions, and documentation of product suitability, ensuring that vendors provide products with a minimum expiration of one year from the delivery date. This procurement is crucial for maintaining the supply of essential medications for veterans, with bids due by November 6, 2024, at 4:00 PM CST, and interested vendors can contact Sarah Fry at sarah.fry2@va.gov for further information.

    Point(s) of Contact
    Sarah Fry
    (913) 758-9935
    sarah.fry2@va.gov
    Files
    Title
    Posted
    S02_Pricing Schedule_Q0016.xlsx
    The CMOP Lancaster RFQ (36C77025Q0016) outlines a procurement request for pharmaceutical supplies, specifically ACAMPROSATE CA 333MG EC Tablets (NDC: 00378-6333-80), requiring delivery within 10 days after receipt of order. Vendors must submit quotes via email by November 6, 2024, before 4:00 PM CST, using the provided solicitation documents, including a signed SF1449 cover page and a completed quote spreadsheet. Essential eligibility documents include a valid State Wholesale Distributor License, a BAA Certificate for non-domestic quotes, and a stipulation that all pharmaceutical products must have a minimum expiration of one year from the delivery date. Vendors are instructed to adjust quantities based on any discrepancies in the quoted NDC and to state any short-dated items in the comments section. This RFQ promotes compliance with the Buy American Act and features a small business set-aside, ensuring that local businesses are prioritized for procurement opportunities. Overall, this document serves to facilitate the acquisition of essential medical supplies while adhering to federal regulations.
    S02_RFQ_36C77025Q0016.pdf
    The document outlines a Request for Quotation (RFQ) issued by the Department of Veterans Affairs for the procurement of pharmaceuticals, specifically Acamprosate CA 333MG EC Tablets. The RFQ includes details related to contractor information, solicitation dates, and delivery terms, emphasizing that bids are open to small businesses and other specified categories. The RFQ mandates compliance with several guidelines, encompassing pharmaceutical labeling, delivery conditions, and invoicing requirements. Critical details include the need for proper barcoding, shipment coordination with receiving facilities, and documentation of product suitability such as valid wholesale distributor licenses. Vendors must ensure product availability, adhere to Drug Supply Chain Security Act requirements, and provide a National Drug Code (NDC) for each quoted product. Failure to meet these criteria may result in the rejection of offers. The document serves as a framework for the solicitation process, ensuring that all bids comply with federal regulations and that the VA can procure the necessary medications efficiently and effectively.
    S03_PRE_SOL_Q0016.pdf
    The Department of Veterans Affairs (VA) is preparing to release a Request for Quotation (RFQ) for the procurement of Acamprosate Calcium (333 mg EC Tablets) for its Lancaster CMOP facility. The solicitation number is 36C77025Q0016, with responses due by November 6, 2024, at 4 PM Central Time. This procurement is set aside for small businesses under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505 (Drugs and Biologicals). Vendors must be registered in SAM.gov and are required to submit essential documents including a signed SF1449 cover page, a price schedule in Excel format, and proof of state wholesale distributor licensure. Compliance with the Drug Supply Chain Security Act and, if applicable, a Buy American Act Certificate for non-domestic items, is mandatory for bid consideration. The estimated issue date for the RFQ is October 30, 2024, with delivery expected within 10 days after receipt of order. All quotations must be submitted via email to the designated Contract Specialist, Sarah Fry. This solicitation emphasizes ensuring that all participants adhere to regulatory standards and provides a structured approach for vendor compliance.
    Similar Opportunities
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the supply of Norethindrone Acetate Tablets under Request for Proposal (RFP) 36E79724R0027. The procurement aims to establish contracts for the pharmaceutical product, with specific requirements regarding pricing for a base year and four option years, compliance with packaging standards, and adherence to the Drug Supply Chain Security Act (DSCSA) regulations. This medication is essential for various health treatments within the VA system, ensuring that veterans receive necessary pharmaceutical care. Interested contractors must submit their proposals by November 15, 2024, at 2:30 PM Central Standard Time, to the designated email addresses provided in the solicitation documents. For further inquiries, potential bidders can contact Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0052 770-25-1-801-0071 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking bids for an emergency procurement of Ferrous Sulfate 324MG EC Tablets, specifically packaged in bottles of 100, to be delivered to various Consolidated Mail Outpatient Pharmacy (CMOP) facilities across the United States. The procurement requires a total of seven different quantities ranging from 1,200 to 9,600 units, with a delivery timeframe of 10 days after receipt of order (ARO). This initiative is crucial for maintaining a reliable pharmaceutical supply chain to support the healthcare needs of veterans. Interested vendors must submit their proposals by November 6, 2024, at 9:00 AM CST, including a signed SF1449 cover page, a price schedule in Excel format, a state wholesale distributor license, and a completed Trade Agreements Certificate, with the estimated award date set for November 12, 2024. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to ensure an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will have a duration of one year, with the potential for four additional one-year options, and the estimated annual requirements include specific dosages and quantities of the tablets. Interested vendors must submit their proposals by December 4, 2024, and are encouraged to check SAM.gov for updates regarding the solicitation. For inquiries, vendors can contact Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or by phone at 708-786-5894.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Omeprazole Dr Capsules- NAC Repack
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) 36E79725R0002 for the procurement of Omeprazole DR Capsules, aimed at supporting various health service agencies, including the VA, Bureau of Prisons, and others. This unrestricted procurement will award one contract per group, with a total contract duration of one year and the potential for four additional one-year option periods. The procurement is critical for ensuring a reliable supply of essential medications, with specific packaging requirements including safety caps and unique NDC numbers for the products. Interested offerors should note that the solicitation is expected to be released electronically on or around November 19, 2024, with a closing date of December 3, 2024. For further inquiries, interested parties can contact Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Calcitonin Gene-Related Peptides (CGRP) through its Pharmaceutical Prime Vendor (PPV) Program. This procurement aims to establish a contract that ensures a consistent supply of these pharmaceutical products while adhering to federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). The CGRP products are critical for various medical treatments within VA facilities, emphasizing the importance of quality control and reliable delivery. Interested offerors must submit their proposals by November 7, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--770-25-1-801-0021 -National CMOP DORZOLAMIDE/TIMOLOL -VA-25-00011267)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure DORZOLAMIDE/TIMOLOL ophthalmic solution for its Centralized Mail Order Pharmacy (CMOP) facilities. This procurement involves acquiring quantities ranging from 2,880 to 9,600 units of 10ML packaging, with a focus on ensuring compliance with the Drug Supply Chain Security Act and other regulatory standards. The pharmaceutical products are critical for providing necessary medical care to veterans, reflecting the VA's commitment to delivering high-quality healthcare solutions. Interested vendors must submit their quotations by November 12, 2024, following the release of the solicitation on November 4, 2024, and can direct inquiries to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77025Q0050 760-25-1-050-0022 - Leavenworth CMOP AMLODIPINE (VA-25-00014183)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) facility in Leavenworth, Kansas, under solicitation number 36C77025Q0050. The procurement includes a range of medications, with specific quantities and packaging requirements, emphasizing compliance with the Drug Supply Chain Security Act and the Buy American statute. This initiative is crucial for ensuring a reliable supply of essential medications for veteran care services. Interested vendors must submit their quotes, including a signed SF1449 cover page, a price schedule in Excel format, and a state wholesale distributor license, by November 6, 2024, with an anticipated award date of November 13, 2024. For further inquiries, vendors can contact Jeffrey Blackard at Jeffrey.Blackard@va.gov or (913) 684-0142.